Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Brain Topography|July 15, 2026
Dopaminergic Drugs Modulate Resting-State EEG Microstates in Healthy ParticipantsRenate de Bock, Amatya J Mackintosh, Alexandra Korda, et al.Cancer Letters|March 26, 2013
Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapyTomohiro Shimizu, María P Torres, Subhankar Chakraborty, et al.Computational Psychiatry (Cambridge, Mass.)|May 22, 2024
Altered Perception of Environmental Volatility During Social Learning in Emerging PsychosisDaniel J Hauke, Michelle Wobmann, Christina Andreou, et al.European Journal of Cancer (Oxford, England : 1990)|June 4, 2013
Phase Ib study of tivozanib (AV-951) in combination with temsirolimus in patients with renal cell carcinomaM N Fishman, S Srinivas, R J Hauke, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2023
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivityPeter Bedford, Daniel J Hauke, Zheng Wang, et al.Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|August 3, 2023
Aberrant Hierarchical Prediction Errors Are Associated With Transition to Psychosis: A Computational Single-Trial Analysis of the Mismatch NegativityDaniel J Hauke, Colleen E Charlton, André Schmidt, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigensGeorge P Hemstreet, Gabriela R Rossi, Vladimir M Pisarev, et al.Scientific Reports|June 13, 2019
Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approachOleg Bykowsky, Fabienne Harrisberger, André Schmidt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2011
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trialSeza A Gulec, Steven J Cohen, Kenneth L Pennington, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2016
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network studyNabil Adra, Costantine Albany, Mary J Brames, et al.Pageof 9